Skip to content
    SOLS
    Earnings call· Mar 2026(Q1 FY26)

    Solstice Advanced Materials Q1 FY26 earnings call SOLS

    May 6, 2026 Source

    Executive summary

    Solstice Advanced Materials Q1 FY26 — Strong Start Driven by Electronic Materials and Nuclear

    Solstice Advanced Materials delivered a strong Q1 FY26, exceeding revenue guidance, driven by robust demand in Electronic Materials, Nuclear, and Refrigerants for data centers. The company reaffirmed its full-year guidance, citing strong momentum and strategic investments in high-return growth areas. Management emphasized disciplined capital allocation, balancing growth initiatives with shareholder returns, while navigating a dynamic macro environment and geopolitical uncertainties.

    Highlights

    5

    • Net sales reached $991 million, up 10% year-over-year, exceeding the top end of guidance.

    • Organic net sales grew 8%, comprising 6% from volume growth and 2% from pricing.

    • Electronic Materials revenue increased 21% year-over-year, driven by robust demand in semiconductor applications.

    • Nuclear business net sales were up 27% year-over-year, reflecting favorable pricing and increased volumes.

    • Generated nearly $200 million in operating cash flow, enabling growth investments and shareholder returns.

    Concerns

    3

    • Adjusted EBITDA margin for the Refrigerants & Applied Solutions segment declined 522 basis points year-over-year due to anticipated refrigerant mix shifts and higher R&D spending.

    • GAAP net income decreased primarily due to higher SG&A and interest expense associated with operating as a standalone public company.

    • Noncontrolling interest was atypically high at $20 million in Q1, driven by favorable ConverDyn margins and a consolidated entity impact.

    Guidance & targets

    6
    CategoryTargetConfidence
    Full-year 2026 Net Sales
    $3.9 billion - $4.1 billion
    high materiality
    High
    Full-year 2026 Adjusted EBITDA
    $975 million - $1.025 billion
    high materiality
    High
    Full-year 2026 Adjusted Diluted EPS
    $2.45 - $2.75
    high materiality
    High
    Full-year 2026 Capital Expenditures
    $400 million - $425 million
    medium materiality
    High
    Q2 2026 Net Sales
    $1.06 billion - $1.1 billion
    medium materiality
    High
    Q2 2026 Adjusted EBITDA Margin
    25% - 26%
    medium materiality
    High

    Segment performance

    9
    SegmentRevenueYoYQoQMargin
    Refrigerants & Applied Solutions
    Growth driven by strong demand for refrigerants and Nuclear business. Adjusted EBITDA declined due to anticipated shifts in refrigerant mix and higher R&D spending.
    Adjusted EBITDA Margin: 34.1%Organic Net Sales Growth: 9%Foreign Currency Translation Impact: 3% increase
    		$711 million12%—$242 million Adjusted EBITDA
    Refrigerants
    Driven by favorable pricing and volume growth, strong demand for 454B, and accelerating orders for data centers.
    		$389 million19%——
    Nuclear
    Reflecting favorable pricing and increased volumes, well positioned for the advanced nuclear renaissance.
    		$107 million27%——
    Building Solutions & Intermediate
    Impacted by continued softness in the construction market.
    		$167 million-8%——
    Healthcare Packaging
    Increase driven by a recovery in customer demand patterns following destocking in H2 2025.
    		$47 million9%——
    Electronic & Specialty Materials
    Increase primarily driven by volume growth in Electronic Materials.
    Adjusted EBITDA Margin: 20.8%Organic Net Sales Growth: 5%Foreign Currency Translation Impact: 3% increase
    		$281 million7%—$58 million Adjusted EBITDA
    Electronic Materials
    Driven by volume growth and robust customer demand across semiconductor applications, especially for AI and data centers.
    		$109 million21%——
    Safety & Defense Solutions
    Anticipates strong growth in Q2 based on order patterns; investing in capacity expansion for Spectra line.
    		$50 millionFlat——
    Research & Performance Chemicals
    Growth in bind chemicals offset by ongoing end market softness in specialty additives.
    		$121 millionSteady——

    Operational metrics

    16
    Capital Expenditures
    $82 million32% increase YoY
    Q1 FY26

    Due to planned increases in capital spending to drive long-term growth in high-return areas.

    Long-term debt
    $2 billion
    As of March 31, 2026

    Part of conservative leverage profile.

    Cash and cash equivalents
    $642 million
    As of March 31, 2026

    Part of strong liquidity position.

    Net debt
    $1.3 billion
    As of March 31, 2026

    Calculated from long-term debt and cash.

    Net leverage ratio
    1.4x
    As of March 31, 2026

    Reflects conservative leverage profile.

    Revolving credit facility availability
    $1 billion
    As of March 31, 2026

    Contributes to total liquidity.

    Total liquidity
    $1.6 billion
    As of March 31, 2026

    Combined cash and revolving credit facility availability.

    Quarterly dividend
    $0.075in line with last quarter
    Q1 FY26

    Approved as part of capital allocation approach.

    Organic Net Sales Growth
    8%
    Q1 FY26

    Key driver of net sales performance.

    Foreign Currency Translation Impact on Net Sales
    2.5% increase
    Q1 FY26

    Contributed to overall net sales growth.

    Noncontrolling Interest
    $20 million
    Q1 FY26

    Atypically high this quarter due to favorable ConverDyn margins and Sinochem JV impact.

    TSA Costs
    $15 million
    Q1 FY26

    On track with spin transition, expected to decrease significantly next year.

    Refrigerant Mix (HFOs vs HFCs)
    60% HFOs, 40% HFCs
    Early 2026

    Strategic shift towards HFOs for long-term growth and market leadership.

    Nuclear Volume Increase from Debottlenecking
    25%
    From 2024 numbers

    Debottlenecking efforts are going extremely well.

    Nuclear Loan Repayment Impact
    $30 million
    FY26

    Once complete, all loan returns will be finished.

    Planned Downtime Related Expense
    $10 million
    Q2 FY26

    Contemplated in Q2 outlook, related to 5 planned maintenance outages.

    Industry KPIs

    1
    MetricValueDetails
    Volume vs price split8%%

    Capital programs

    1
    Spokane, Washington facility expansionunderway$200 million

    Benefit: double capacity for sputtering targets

    Investment to reduce customer lead times and provide sustainability benefits; expected to exceed mid-teens percentage IRR.

    Risks & headwinds

    5
    Refrigerant mix shift and higher R&D spending impacting RAS segment marginQ1 FY26

    RAS adjusted EBITDA margin down 522 basis points YoY

    Mitigation: Expect sequential refrigerant margin improvement from Q1 levels as the aftermarket develops.

    Increased costs due to Middle East conflictQ1 FY26 and ongoing

    Impact on logistics costs (diesel fuel, shipping) and raw materials (sulfuric acid); represents less than 10% of total materials spend.

    Mitigation: Partnering with customers to offset inflation with pricing actions; leveraging strong analytical tools for price/cost management.

    Geopolitical environment uncertaintyOngoing

    Not quantified, but led to conservative stance in full-year guidance.

    Mitigation: Will re-evaluate guidance after Q2 if the geopolitical environment subsides.

    Costs associated with being a standalone public companyQ1 FY26 and ongoing

    Higher SG&A and interest expense, contributing to GAAP net income decrease.

    Mitigation: TSA costs are expected to decrease significantly next year, improving profitability.

    Planned maintenance outagesQ2 FY26

    $10 million of related expense

    Mitigation: 5 planned outages, everything on track so far.

    What to watch in Q2 FY26

    5

    Nuclear business expansion study update

    Later this year
    CurrentEngineering firm engaged, discussions with customers/regulators underway
    TargetMore details on engineering work

    Why it matters

    Significant long-term growth potential for the Nuclear business, crucial for future capacity planning.

    We will probably be in a position to share more on the engineering work we're doing later this year.

    Q&A highlights

    8

    What were the volume and price contributions to Nuclear's 27% sales growth? Can you update on the $30 million loan repayment and long-term expansion plans?

    Nuclear growth was driven by both price and volume. The $30 million loan repayment will primarily impact H2 2026. Debottlenecking will increase volume by 25% from 2024. An engineering study for significant expansion beyond 2030s is underway, with more details expected later this year, alongside ongoing discussions with customers and regulators.

    “Our debottlenecking efforts are going extremely well. We feel very good about the 25% increase in volume that we're going to deliver from our 2024 numbers. And then on the future expansion, we are going down 2 paths right now.”

    asked by Kevin McCarthy · answered by David Sewell

    2 min read5 chapters

    Detailed Narrative

    01

    Strategic Growth Investments

    Solstice is actively investing in high-growth areas aligned with its strategic pillars, including Electronic Materials, Safety & Defense Solutions, and Nuclear businesses. A significant investment of $200 million is underway at the Spokane, Washington facility to double capacity for sputtering targets, aiming to reduce lead times and improve sustainability. This project is expected to exceed the company's mid-teens percentage internal rate of return (IRR) hurdle rate, underscoring a commitment to high-return capital deployment. The company is also evaluating opportunities to accelerate similar organic growth investments and strengthen its innovation pipeline.

    02

    Refrigerants and Data Center Opportunities

    The Refrigerants & Applied Solutions (RAS) segment is experiencing strong double-digit growth in refrigerants for data centers, driven by accelerating orders and secular trends in high-performance computing. Solstice is developing a pipeline of next-generation molecules for advanced cooling solutions, including 2-phase direct-to-chip and immersion cooling, to address the increasing heat generated by advanced semiconductor nodes. This R&D investment is a key focus, with co-innovation efforts alongside customers to meet future cooling demands and explore heat repurposing for nearby communities.

    03

    Nuclear Business Expansion

    The Nuclear business delivered strong Q1 performance with 27% year-over-year sales growth, benefiting from both favorable pricing and increased volumes. Debottlenecking efforts are on track to deliver a 25% volume increase from 2024 levels. Looking further ahead, Solstice has engaged an engineering firm to study options for significant production capacity expansion beyond the 2030s, driven by anticipated global demand for nuclear energy and the acceleration of Small Modular Reactors (SMRs). Discussions with customers and U.S. regulators are ongoing to support these expansion plans.

    04

    Capital Allocation and Financial Flexibility

    Solstice maintains a strong balance sheet and conservative leverage profile, with $1.3 billion in net debt and a net leverage ratio of approximately 1.4x trailing 12-month adjusted EBITDA. The company generated $199 million in operating cash flow in Q1, which is being used to fund growth investments and return capital to shareholders. A quarterly dividend of $0.075 per share was approved, consistent with the prior quarter, reflecting a disciplined approach to capital allocation and shareholder returns.

    05

    Operational Execution and Cost Management

    The company achieved 8% organic net sales growth in Q1, composed of 6% volume growth and 2% pricing, demonstrating effective operational execution. Despite inflationary impacts from the Middle East conflict affecting logistics and raw materials like sulfuric acid, Solstice has successfully partnered with customers to offset these costs through pricing actions. The company's experience from 2021-2022 and strong analytical tools position it well to manage price/cost dynamics throughout the year.

    AI-generated summary of the company’s earnings call. Not investment advice.